These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1034 related articles for article (PubMed ID: 9452302)
21. Clinical and epidemiologic studies of Chagas' disease in rural communities of Oaxaca, Mexico, and an eight-year followup: II. Chila. Goldsmith RS; Zárate RJ; Zárate LG; Morales G; Kagan I; Drickey R; Jacobson LB Bull Pan Am Health Organ; 1992; 26(1):47-59. PubMed ID: 1600437 [TBL] [Abstract][Full Text] [Related]
22. Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease. Vitelli-Avelar DM; Sathler-Avelar R; Mattoso-Barbosa AM; Gouin N; Perdigão-de-Oliveira M; Valério-Dos-Reis L; Costa RP; Elói-Santos SM; Gomes MS; Amaral LR; Teixeira-Carvalho A; Martins-Filho OA; Dick EJ; Hubbard GB; VandeBerg JF; VandeBerg JL PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005233. PubMed ID: 28225764 [TBL] [Abstract][Full Text] [Related]
23. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Brener Z; Gazzinelli RT Int Arch Allergy Immunol; 1997 Oct; 114(2):103-10. PubMed ID: 9338602 [TBL] [Abstract][Full Text] [Related]
24. Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection. de Souza SM; Vieira PM; Roatt BM; Reis LE; da Silva Fonseca K; Nogueira NC; Reis AB; Tafuri WL; Carneiro CM Mol Immunol; 2014 Mar; 58(1):92-7. PubMed ID: 24317279 [TBL] [Abstract][Full Text] [Related]
25. Circulating Cytokine and Chemokine Profiles of Trypanosoma cruzi-Infected Women During Pregnancy and Its Association With Congenital Transmission. Volta BJ; Bustos PL; González C; Natale MA; Perrone AE; Milduberger N; Laucella SA; Bua J J Infect Dis; 2021 Sep; 224(6):1086-1095. PubMed ID: 33528501 [TBL] [Abstract][Full Text] [Related]
26. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease. Barry MA; Wang Q; Jones KM; Heffernan MJ; Buhaya MH; Beaumier CM; Keegan BP; Zhan B; Dumonteil E; Bottazzi ME; Hotez PJ Hum Vaccin Immunother; 2016 Apr; 12(4):976-87. PubMed ID: 26890466 [TBL] [Abstract][Full Text] [Related]
27. Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine. Rosas-Jorquera CE; Sardinha LR; Pretel FD; Bombeiro AL; D'Império Lima MR; Alvarez JM Clin Vaccine Immunol; 2013 Feb; 20(2):248-54. PubMed ID: 23254299 [TBL] [Abstract][Full Text] [Related]
28. Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi. Gao W; Pereira MA Int J Parasitol; 2002 Feb; 32(2):167-70. PubMed ID: 11812493 [TBL] [Abstract][Full Text] [Related]
29. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection. Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727 [TBL] [Abstract][Full Text] [Related]
30. Chagas Disease Control Programme in Brazil: a study of the effectiveness of 13 years of intervention. Costa FC; Vitor RW; Antunes CM; Carneiro M Bull World Health Organ; 1998; 76(4):385-91. PubMed ID: 9803589 [TBL] [Abstract][Full Text] [Related]
31. Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection. Sanoja C; Carbajosa S; Fresno M; Gironès N PLoS One; 2013; 8(6):e65820. PubMed ID: 23776551 [TBL] [Abstract][Full Text] [Related]
32. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction? Basso B; Marini V Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810 [TBL] [Abstract][Full Text] [Related]
33. Activation of Human CD11b Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO Front Immunol; 2018; 9():3015. PubMed ID: 30662439 [TBL] [Abstract][Full Text] [Related]
35. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease]. Braun M; de Titto E Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884 [TBL] [Abstract][Full Text] [Related]
36. Seroprevalence and sociocultural conditionants of Chagas disease in school-aged children of marginal zones of Asunción. Vera NI; Maldonado M; Yaluff G; Simancas L; de Arias AR Rev Soc Bras Med Trop; 1998; 31(4):347-53. PubMed ID: 9662961 [TBL] [Abstract][Full Text] [Related]
37. Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi. Lorena VM; Verçosa AF; Machado RC; Moitinho-Silva L; Cavalcanti MG; Silva ED; Ferreira AG; Correa-Oliveira R; Pereira VR; Gomes YM J Clin Lab Anal; 2008; 22(2):91-8. PubMed ID: 18348314 [TBL] [Abstract][Full Text] [Related]